Coordinated regulation of MAP kinase signaling by ubiquitination
通过泛素化协调调节 MAP 激酶信号传导
基本信息
- 批准号:8223685
- 负责人:
- 金额:$ 2.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressApoptosisBehaviorCardiacCell ProliferationCellsCompetenceComplexCullin ProteinsDataDiabetes MellitusDiseaseEnvironmentEnzymesEukaryotaEukaryotic CellEventF Box DomainFeedbackG-Protein-Coupled ReceptorsGTP-Binding ProteinsGene ExpressionGenetic TranscriptionHeterotrimeric GTP-Binding ProteinsImmune System DiseasesImmunoblottingIn VitroLibrariesLinkLupusMalignant NeoplasmsMass Spectrum AnalysisMediatingMembrane Protein TrafficMethodsMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesModelingMorphologyMutateMutationMyopathyOrganismOutputParkinson DiseasePartner in relationshipPathway interactionsPheromonePhosphorylationPhosphorylation SitePhosphotransferasesPost-Translational Protein ProcessingProteinsRegulationRelative (related person)RoleSaccharomyces cerevisiaeSaccharomycetalesScaffolding ProteinSeriesSignal PathwaySignal TransductionSignal Transduction PathwaySignaling ProteinSiteSpecificitySubstrate SpecificitySystemTestingUbiquitinUbiquitin-Activating EnzymesUbiquitin-Conjugating EnzymesUbiquitinationVirus DiseasesYeastsbasecombathuman diseasemigrationnervous system disorderprotein protein interactionpublic health relevanceresearch studyresponseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Ubiquitination is a posttranslational modification that instigates proteasomal degradation of its target proteins. In recent years, the function of ubiquitination has expanded to include roles in membrane trafficking, protein-protein interactions, gene transcription, and kinase activation. Three enzymes mediate ubiquitination: the E1 ubiquitin-activating enzyme, the E2 ubiquitin-conjugating enzyme, and the E3 ubiquitin ligase, which determines the specificity of ubiquitination. Mutations of Skp1/Cullin/F-box E3 ubiquitin ligase complexes (SCF) have been linked to many human diseases, including multiple forms of cancer, immune disorders such as diabetes and lupus, neurological disorders like Parkinson's disease, viral infections, and cardiac myopathies. Our lab has recently demonstrated that a functional SCF complex is required for proper pheromone response in the budding yeast S. cerevisiae. The yeast pheromone response pathway is one of the best-characterized signal transduction pathways, consisting of a canonical G-protein coupled receptor (GPCR), heterotrimeric G- protein, and mitogen-activated protein kinase (MAPK) signaling cascade. Moreover, this signaling pathway has been used to identify multiple cell signaling mechanisms that are conserved in virtually all eukaryotes. We and others have demonstrated that the SCF complex is required for ubiquitination of multiple signaling components within the pheromone response pathway, including the G1 subunit Gpa1, the MAPK kinase Ste7, the scaffold protein Ste5, and the effector Far1. Further, we have recently generated data in our lab demonstrating that ubiquitination alters the selectivity of Ste7 activation of the downstream MAPKs Fus3 and Kss1. Based on these data, we hypothesize that SCF-mediated ubiquitination of Ste7 regulates its ability to selectively activate downstream signaling proteins. We further hypothesize that SCF is a master regulator of the MAPK signaling cascade, acting simultaneously on multiple pathway components to dictate overall pathway output. This hypothesis will be addressed through the following specific aims: Aim #1: Determine how ubiquitination modulates the activity and specificity of the pheromone pathway MAPKK Ste7. Aim #2: Systematically identify all proteins in the pheromone response pathway that are ubiquitinated by the SCF E3 ubiquitin ligase complex. The proposed studies will define how ubiquitination influences the signaling behavior of a target protein, determine the contribution of ubiquitination to overall signaling pathway output, and expand our understanding of how the highly-conserved MAPK cascade is regulated.
PUBLIC HEALTH RELEVANCE: Cellular signaling pathways regulate how cells respond to their environment. Incorrect cellular signaling causes many human diseases including cancer, immune disorders like diabetes and lupus, and neurological disorders such as Parkinson's disease. This proposal aims to identify a new mechanism that regulates cellular signaling and possibly reveal new ways to modulate signaling pathways to combat disease.
描述(由申请人提供):泛素化是一种翻译后修饰,可引发其靶蛋白的蛋白酶体降解。近年来,泛素化的功能已扩展到包括膜运输、蛋白质-蛋白质相互作用、基因转录和激酶激活中的作用。三种酶介导泛素化:E1 泛素激活酶、E2 泛素结合酶和 E3 泛素连接酶,它决定泛素化的特异性。 Skp1/Cullin/F-box E3 泛素连接酶复合物 (SCF) 的突变与许多人类疾病有关,包括多种癌症、糖尿病和狼疮等免疫疾病、帕金森病等神经系统疾病、病毒感染和心肌病。我们的实验室最近证明,芽殖酵母酿酒酵母中适当的信息素反应需要功能性 SCF 复合物。酵母信息素响应途径是最具特征的信号转导途径之一,由典型的 G 蛋白偶联受体 (GPCR)、异三聚体 G 蛋白和丝裂原激活蛋白激酶 (MAPK) 信号级联组成。此外,该信号传导途径已用于识别几乎所有真核生物中保守的多种细胞信号传导机制。我们和其他人已经证明,SCF 复合物是信息素响应途径内多个信号成分泛素化所必需的,包括 G1 亚基 Gpa1、MAPK 激酶 Ste7、支架蛋白 Ste5 和效应器 Far1。此外,我们最近在实验室中生成的数据表明,泛素化改变了下游 MAPK Fus3 和 Kss1 的 Ste7 激活的选择性。基于这些数据,我们假设 SCF 介导的 Ste7 泛素化调节其选择性激活下游信号蛋白的能力。我们进一步假设 SCF 是 MAPK 信号级联的主要调节器,同时作用于多个通路组件以决定整体通路输出。这一假设将通过以下具体目标得到解决: 目标#1:确定泛素化如何调节信息素途径 MAPKK Ste7 的活性和特异性。目标#2:系统地识别信息素响应途径中被 SCF E3 泛素连接酶复合物泛素化的所有蛋白质。 拟议的研究将定义泛素化如何影响靶蛋白的信号行为,确定泛素化对整体信号通路输出的贡献,并扩大我们对高度保守的 MAPK 级联如何调节的理解。
公共卫生相关性:细胞信号通路调节细胞对其环境的反应。不正确的细胞信号传导会导致许多人类疾病,包括癌症、糖尿病和狼疮等免疫疾病以及帕金森病等神经系统疾病。该提案旨在确定一种调节细胞信号传导的新机制,并可能揭示调节信号传导途径以对抗疾病的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jillian Heyward Hurst其他文献
Jillian Heyward Hurst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jillian Heyward Hurst', 18)}}的其他基金
Clinical and host microbiome features in the development of acute otitis media
急性中耳炎发生过程中的临床和宿主微生物组特征
- 批准号:
10735848 - 财政年份:2023
- 资助金额:
$ 2.61万 - 项目类别:
Coordinated regulation of MAP kinase signaling by ubiquitination
通过泛素化协调调节 MAP 激酶信号传导
- 批准号:
8060988 - 财政年份:2011
- 资助金额:
$ 2.61万 - 项目类别:
相似国自然基金
柔性凋亡细胞仿生体调控巨噬细胞行为的协同机制及其用于抑制骨关节炎软骨退变
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
金属硫蛋白MT1介导癌-睾丸抗原CT23影响肝癌恶性生物学行为的研究
- 批准号:81760424
- 批准年份:2017
- 资助金额:34.0 万元
- 项目类别:地区科学基金项目
有丝分裂阻滞期选择性翻译受体Notch2调控细胞行为和命运的机制研究
- 批准号:31771498
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
细胞凋亡调控因子Bcl-xL、Bax、tBid的相互作用、构象变化和寡聚行为研究
- 批准号:21472206
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
亚致死剂量吡虫啉对蜜蜂脑神经细胞凋亡影响研究
- 批准号:31402148
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Deciphering neural crest-specific TFAP2 pathways in midface development and dysplasia
解读中面部发育和发育不良中神经嵴特异性 TFAP2 通路
- 批准号:
10676016 - 财政年份:2023
- 资助金额:
$ 2.61万 - 项目类别:
Heat therapy for the treatment of SCI-induced changes in nociceptor and mitochondrial function
热疗法治疗 SCI 引起的伤害感受器和线粒体功能变化
- 批准号:
10641385 - 财政年份:2023
- 资助金额:
$ 2.61万 - 项目类别:
The role of VMAT-2 in mediating the impact of HIV-1 protein Tat and methamphetamine on dopamine neurotransmission and behavior
VMAT-2在介导HIV-1蛋白Tat和甲基苯丙胺对多巴胺神经传递和行为的影响中的作用
- 批准号:
10547890 - 财政年份:2023
- 资助金额:
$ 2.61万 - 项目类别:
MRI Study of Hydrogen Water and Minocycline Combination Therapy for Ischemic Stroke
氢水与米诺环素联合治疗缺血性中风的MRI研究
- 批准号:
10564735 - 财政年份:2023
- 资助金额:
$ 2.61万 - 项目类别:
Using natural killer cells to prevent breast cancer metastases
使用自然杀伤细胞预防乳腺癌转移
- 批准号:
10591362 - 财政年份:2023
- 资助金额:
$ 2.61万 - 项目类别: